Ryan Langston
Stock Analyst at TD Cowen
(2.56)
# 2,860
Out of 4,534 analysts
238
Total ratings
49.7%
Success rate
1.4%
Average return
Main Sectors:
Stocks Rated by Ryan Langston
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ELV Elevance Health | Reiterated: Buy | $400 → $465 | $382.23 | +21.65% | 15 | Jul 17, 2026 | |
| UNH UnitedHealth Group | Rated: Hold | $337 → $430 | $421.55 | +2.00% | 17 | Jul 16, 2026 | |
| ACHC Acadia Healthcare Company | Rated: Buy | $24 → $36 | $34.43 | +4.56% | 14 | Jul 14, 2026 | |
| CNC Centene | Rated: Hold | $47 → $65 | $65.84 | -1.28% | 17 | Jul 14, 2026 | |
| HUM Humana | Rated: Hold | $211 → $350 | $398.20 | -12.10% | 15 | Jul 14, 2026 | |
| MOH Molina Healthcare | Rated: Hold | $163 → $230 | $229.71 | +0.13% | 18 | Jul 14, 2026 | |
| ASTH Astrana Health | Rated: Buy | $45 → $50 | $44.55 | +12.23% | 13 | Jul 14, 2026 | |
| HCA HCA Healthcare | Maintained: Buy | $431 | $370.42 | +16.35% | 15 | Jun 25, 2026 | |
| THC Tenet Healthcare | Rated: Buy | $242 → $233 | $194.38 | +19.87% | 8 | Jun 25, 2026 | |
| UHS Universal Health Services | Rated: Buy | $230 → $197 | $150.64 | +30.78% | 16 | Jun 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $131 | $111.50 | +17.49% | 22 | Jun 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $125 | $112.50 | +11.11% | 2 | Jun 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 → $17 | $16.03 | +6.05% | 11 | May 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $14 | $10.61 | +31.95% | 10 | May 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $144 → $201 | $234.10 | -14.14% | 11 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $26.26 | +14.24% | 12 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $25 | $21.10 | +18.48% | 9 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $15 | $122.10 | -87.71% | 8 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $391 → $333 | $283.94 | +17.28% | 4 | Feb 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 | $11.34 | n/a | 1 | Aug 9, 2024 |
Elevance Health
Jul 17, 2026
Reiterated: Buy
Price Target: $400 → $465
Current: $382.23
Upside: +21.65%
UnitedHealth Group
Jul 16, 2026
Rated: Hold
Price Target: $337 → $430
Current: $421.55
Upside: +2.00%
Acadia Healthcare Company
Jul 14, 2026
Rated: Buy
Price Target: $24 → $36
Current: $34.43
Upside: +4.56%
Centene
Jul 14, 2026
Rated: Hold
Price Target: $47 → $65
Current: $65.84
Upside: -1.28%
Humana
Jul 14, 2026
Rated: Hold
Price Target: $211 → $350
Current: $398.20
Upside: -12.10%
Molina Healthcare
Jul 14, 2026
Rated: Hold
Price Target: $163 → $230
Current: $229.71
Upside: +0.13%
Astrana Health
Jul 14, 2026
Rated: Buy
Price Target: $45 → $50
Current: $44.55
Upside: +12.23%
HCA Healthcare
Jun 25, 2026
Maintained: Buy
Price Target: $431
Current: $370.42
Upside: +16.35%
Tenet Healthcare
Jun 25, 2026
Rated: Buy
Price Target: $242 → $233
Current: $194.38
Upside: +19.87%
Universal Health Services
Jun 22, 2026
Rated: Buy
Price Target: $230 → $197
Current: $150.64
Upside: +30.78%
Jun 18, 2026
Reiterated: Buy
Price Target: $131
Current: $111.50
Upside: +17.49%
Jun 16, 2026
Maintained: Buy
Price Target: $125
Current: $112.50
Upside: +11.11%
May 27, 2026
Maintained: Buy
Price Target: $20 → $17
Current: $16.03
Upside: +6.05%
May 22, 2026
Rated: Hold
Price Target: $3 → $14
Current: $10.61
Upside: +31.95%
May 11, 2026
Rated: Hold
Price Target: $144 → $201
Current: $234.10
Upside: -14.14%
May 11, 2026
Maintained: Buy
Price Target: $30
Current: $26.26
Upside: +14.24%
May 4, 2026
Rated: Buy
Price Target: $25
Current: $21.10
Upside: +18.48%
Feb 27, 2026
Maintained: Hold
Price Target: $25 → $15
Current: $122.10
Upside: -87.71%
Feb 4, 2026
Reiterated: Buy
Price Target: $391 → $333
Current: $283.94
Upside: +17.28%
Aug 9, 2024
Rated: Hold
Price Target: $7
Current: $11.34
Upside: n/a